Form D · Biotechnology
Daktari Diagnostics, Inc.
Cambridge, MA · CIK 0001470342
Offering snapshot reported May 25, 2016 · SEC filing
- Reported sold
- $22.5M Offering amount: $22.5M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 2, 2015 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$15,499,999 → $22,499,999
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 25, 2016 | Amendment | $22,499,999 | $7,000,000vs Mar 13, 2015 | 31 | SEC filing |
| Mar 13, 2015 | Initial | $15,499,999 | No comparison | 31 | SEC filing |
| Apr 7, 2014 | Amendment | $19,999,995 | $12,999,995vs May 13, 2013 | 27 | SEC filing |
| May 13, 2013 | Initial | $7,000,000 | No comparison | 26 | SEC filing |
| Dec 27, 2011 | Initial | $4,999,987 | No comparison | 41 | SEC filing |
| Aug 16, 2011 | Initial | $1,178,530 | No comparison | 30 | SEC filing |
| Nov 3, 2010 | Initial | $1,800,000 | No comparison | 32 | SEC filing |
| Jul 2, 2010 | Initial | $820,000 | No comparison | 42 | SEC filing |
| Aug 26, 2009 | Initial | $2,547,254 | No comparison | 39 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-235859
Source: Form D, filed May 25, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thierry Bernard | Director |
| Michael Crowley | Executive |
| Christopher Earl | Director |
| Donald Hawthorne | Director, Executive |
| Peter Kaspar | Director |
| Roger Kitterman | Director |
| Stanley Lapidus | Director |
| Edward Roberts | Director |
| William Rodriguez | Director, Executive |
| David Rubin | Director |
| Aaron Sandoski | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
85 Bolton Street
Cambridge, MA, 02140
Cambridge, MA, 02140